Table: begin end state 1 15 cytoplasmic 16 36 transmembrane 37 51 non-cytoplasmic 52 71 transmembrane 72 82 cytoplasmic 83 101 transmembrane 102 106 non-cytoplasmic 107 128 transmembrane 129 139 cytoplasmic 140 161 transmembrane 162 172 non-cytoplasmic 173 192 transmembrane 193 222 cytoplasmic 223 244 transmembrane 245 254 non-cytoplasmic 255 279 transmembrane 280 298 cytoplasmic 299 317 transmembrane 318 322 non-cytoplasmic 323 343 transmembrane 344 358 cytoplasmic 359 380 transmembrane 381 385 non-cytoplasmic 386 408 transmembrane 409 432 cytoplasmic
Input: >AZOBR_RS07945 FitnessBrowser__azobra:AZOBR_RS07945 MRQTGAQSALPVGGRWMQLLAGVICMSMIANLQYGWTLFVEPIDDKHGWGRAAIQVAFTI FIVTETWLVPVEGWFVDRFGPRIVVLFGSVLCAASWALNAVADSLLVLYVAAAIGGIGAG AVYGTCVGNALKWFPDRRGLAAGITAAGFGAGSALTVVPIATMIETSGYEATFMAFGLGQ GLVVFALAWLLVAPPSAPLARGGFATPPAQRQYTPSQMVRTPVFWVMYAMFVMVAGGGLM ATAQLGPIAQDFGLAHAPVSILGLTLPALTFALSIDRVLNGLTRPFFGWVSDHIGRENTM FIAFAIEAVGIVALSLYGRDPVAFVLLTGLVFFAWGEIYSLFPACCADTFGSKFAASNAG LLYTAKGTAALLIPFANIIADATGSWHAVFLLAAAVNALAAVLALFVLRPMRNRMAAESL DARSGRSVTATP
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server